Letter

Hazards of reducing cholesterol

BMJ 1994; 309 doi: 10.1136/bmj.309.6953.541 (Published 20 August 1994)
Cite this as: BMJ 1994;309:541.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. C Lines
  1. Merck, Sharp and Dohme Neuroscience Research Centre, Harlow, Essex CM20 2QR.

    EDITOR, - The paper by Law and colleagues1 has given rise to further debate on the safety of cholesterol reduction. In particular, there has been speculation concerning a disputed increase in deaths from suicide and accidents,2 which might indicate detrimental effects on the central nervous system associated with lowering cholesterol.

    Data gathered during the 8245 patient, 48 week, double blind, placebo controlled, parallel groups, expanded clinical evaluation of lovastatin (EXCEL) study are pertinent …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular